Phthisis Diagnostics Announces First International Distribution Agreement
Simple and cost-efficient molecular products make their way into Latin America. Charlottesville, VA, May 17, 2012 - Phthisis Diagnostics, Inc. is proud to announce the signing of its first distribution agreement for international sales. Bio Products, Inc. will distribute the company’s Simply Molecular® product line throughout Latin America.
Bio Products, Inc. is a privately held American company established in West Palm Beach, Florida, over two decades ago. The company has built a reputation for representing a large number of prestigious manufacturers and distributors to serve the research, medical, and scientific community throughout Latin America.
Phthisis Diagnostics President and Chief Science Officer Crystal Icenhour, PhD, commented, “We are delighted to welcome Bio Products as our first distributor for international sales. This is an important next step in the development of Phthisis Diagnostics’ sales. We are currently engaged in negotiations and look forward to announcing additional international distribution agreements soon.”
Phthisis currently offers the E-Sphere® Simple NA Kit for easily and quickly extracting nucleic acids from various types of samples. Future products will include molecular diagnostics for parasites and fungi, as well as molecular standards for improved laboratory quality control.
Bio Products, Inc. can tailor the ordering process to fit customer needs with standing orders, blanket orders, or reserved stock orders. For more information about Bio Products, Inc., visit www.bioproducts.net.
About Phthisis Diagnostics
Phthisis (TYE-sis) Diagnostics is a rapidly growing biotechnology company developing the Simply Molecular® product line of innovative molecular products designed for speed, accuracy, and ease of use. The Simply Molecular® catalog offers solutions for nucleic acid extraction, molecular diagnostics, and laboratory quality control.
Phthisis Diagnostics develops enzyme-based extraction kits for rapid sample preparation prior to PCR applications in laboratories. This optimized workflow minimizes procedural steps, sample transfers, and potential for error.
Phthisis Diagnostics is also developing molecular diagnostic assays using PCR technology to detect intestinal pathogens associated with diarrheal disease, including Cryptosporidium, Giardia, Microsporidia, and others. For more information, visit www.phthisisdiagnostics.com.
About Molecular Diagnostics
Molecular diagnostics is defined as the use of DNA, RNA, and proteins to test for specific states of health or disease. Molecular diagnostic methods have been increasingly used over the past ten years to improve the sensitivity and speed of diagnosis in infectious diseases. Although their routine use has been primarily limited to the detection of pathogens that are difficult to culture in vitro, ‘real-time’ methods, commercial kits, quantification, and automation will increase their use. Molecular diagnostic methods are now widely used for epidemiological fingerprinting of isolates of public health importance and increasingly being used by clinical laboratories to diagnose genetic and infectious disease.
Dory Hulse, Media Relations
434-964-1037 or 434-242-1333 (mobile)